Skip to main content
Fig. 5 | Acta Veterinaria Scandinavica

Fig. 5

From: Improved pharmacotherapy after revised dosing regimens of two slow-release formulations of benzylpenicillin in an Actinobacillus pleuropneumoniae infection model in pigs

Fig. 5

Parallel Tukey boxplots of serum antibodies to Actinobacillus pleuropneumonia serotype 2 (APP2) in pigs. Serum antibodies were measured after inoculation (Day 0) with APP2. Results are aggregated from one day before inoculation to day 3 for readability since the results are similar for this range. Benzylpenicillin treatment was initiated at the onset of clinical signs which occurred within 24 h after inoculation. The treatment group nomenclature is: the medicinal product, either procaine benzylpenicillin in a water suspension (ETH) or procaine benzylpenicillin in an oil suspension (UPA); dose in mg/kg; dose frequency (once or twice daily) and treatment duration in days. For example, ETH20-2 × 3 should read as: procaine benzylpenicillin in a water suspension 20 mg/kg bodyweight twice daily for three days

Back to article page

Acta Veterinaria Scandinavica

ISSN: 1751-0147